Marino Garcia's most recent trade in Dianthus Therapeutics Inc was a trade of 355,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 3, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dianthus Therapeutics Inc | Marino Garcia | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2026 | 355,000 | 355,000 | - | - | Stock Option (Right to Buy) | |
| Dianthus Therapeutics Inc | Marino Garcia | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2025 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) | |
| Dianthus Therapeutics Inc | Marino Garcia | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 340,000 | 340,000 | - | - | Stock Option (Right to Buy) | |
| Dianthus Therapeutics Inc | Marino Garcia | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 243,000 | 243,000 | - | - | Stock Option (Right to Buy) | |
| Dianthus Therapeutics Inc | Marino Garcia | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) |